Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Share-based Compensation (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Share-based Compensation for 4 consecutive years, with $11.1 million as the latest value for Q4 2025.

  • For Q4 2025, Share-based Compensation changed 0.3% year-over-year to $11.1 million; the TTM value through Dec 2025 reached $44.4 million, down 8.03%, while the annual FY2025 figure was $44.4 million, 8.03% down from the prior year.
  • Share-based Compensation was $11.1 million for Q4 2025 at Day One Biopharmaceuticals, up from $9.6 million in the prior quarter.
  • The five-year high for Share-based Compensation was $13.0 million in Q2 2024, with the low at $5.6 million in Q2 2022.
  • Historically, Share-based Compensation has averaged $10.0 million across 4 years, with a median of $10.2 million in 2023.
  • The largest annual shift saw Share-based Compensation surged 68.3% in 2023 before it decreased 17.25% in 2025.
  • Over 4 years, Share-based Compensation stood at $6.8 million in 2022, then surged by 58.22% to $10.8 million in 2023, then grew by 2.07% to $11.0 million in 2024, then rose by 0.3% to $11.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $11.1 million in Q4 2025, $9.6 million in Q3 2025, and $10.9 million in Q2 2025.